Protective effect of β-glucan on lung injury after cecal ligation and puncture in rats

Intensive Care Medicine

Volumn 31, Issue 6, 2005, Pages 865-870

  Babayigit, Hulya ^a   Kucuk, Can ^a   Sozuer, Erdogan ^a   Yazici, Cevad ^a   Kose, Kader ^a   Akgun, Hulya ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Glucan; Experimental; Lung injury; Neutrophil; Sepsis

Indexed keywords

BETA D GLUCAN; BETA GLUCAN; INTERLEUKIN 6; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CECUM; CONTROLLED STUDY; ENZYME ACTIVITY; LUNG HEMORRHAGE; LUNG INJURY; LUNG LAVAGE; LUNG PARENCHYMA; LYMPHOCYTE; MALE; MONOCYTE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; RAT; SEPSIS;

ANALYSIS OF VARIANCE; ANIMALS; BETA-GLUCANS; BRONCHOALVEOLAR LAVAGE FLUID; IMMUNOLOGIC FACTORS; INTERLEUKIN-6; LEUKOCYTE COUNT; LUNG; MALE; PEROXIDASE; RATS; RATS, WISTAR; RESPIRATORY DISTRESS SYNDROME, ADULT; SEPSIS; SURVIVAL ANALYSIS;

EID: 21244449847     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-005-2629-x     Document Type: Article

References (31)

1. Wickel DJ, Cheadle WG, Jones MA, Garrison RN (1997) Poor outcome from peritonitis is caused by disease peritoneal infection. Ann Surg 225:744-756
2. Poll T, Deventer SJH (1999) Cytokines and anti cytokines in the pathogenesis of sepsis. Infect Dis Clin North Am 13:413-427
3. Parker SJ, Watkins PE (2001) Experimental models of gram negative sepsis. Br J Surg 88:22-30
4. Vincent JL (1997) New therapies in sepsis. Chest 112:330-338
5. Sing B, Doane KJ, Niehaus GD (1998) Ultrastructural and cytochemical evaluation of sepsis-induced changes in the rat pulmonary intravascular mononuclear phagocytes. J Anat 192:13-23
6. Bedirli A, Gokahmetoglu S, Sakrak O, Ersoz N, Ayangil D, Esin H (2003) Prevention of intraperitoneal adhesion formation using beta-glucan after ileocolic anastomosis in a rat bacterial peritonitis model. Am J Surg 185:339-343
7. Mohaghegpur N, Dawson M, Hobbs P, Judd A, Winant R, Dousman L, Waldeck N, Hokama L, Tuse D, Kos F (1995) Glucans as immunological adjuvants. Adv Exp Med Biol 383:13-22
8. Williams DL, Ha T, Li C, Kalbfleish JH, Laffan JJ, Ferguson DA (1999) Inhibiting early activation of tissue nuclear factor-B and nuclear factor interleukin 6 with (1>3)-β-D-glucan increases long-term survival in polymicrobial sepsis. Surgery 126:54-65
9. Wichterman KA, Baue AE, Chaudry IH (1980) Sepsis and septic shock - A review of laboratory models and proposal. J Surg Res 29:189-201
10. Bradley PP, Priebat DA, Christensen RD, Rothstein G (1982) Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78:206-209
11. King J, Deboisblanc BP, Mason CM, Onofrio JM, Lipscomb G, Mercante DE, Summer WR, Nelson S (1995) Effect of granulocyte colony stimulating factor on acute lung injury in the rat. Am J Respir Crit Care Med 151:302-309
12. Sessler CN, Blommfield GL, Fowler AA (1996) Current concept of sepsis and acute lung injury. Clin Chest Med 17:223-235
13. Almdahl SM, Bogwald J, Hoffman J, Seljelid R (1987) Treatment of experimental peritonitis in rats by transfer of peritoneal mononuclear cell from rats by transfer of peritoneal mononuclear cell from rats injected with semisoluble aminated glucan. Acta Chir Scand 153:535-539
14. Liang J, Melican D, Cafro L, Palace G, Fisette L, Armstrong R, Patchen ML (1998) Enhanced clearance of a multiple antibiotic resistant staphylococcus aureus in rats treated with PGG glucan is associated with increased leukocyte counts and increased neutrophil oxidative burst activity. Int J Immunopharmacol 20:595-614
15. Williams DL, Mueller A, Browder W (1995) Preclinical and clinical evaluation of carbohydrate immunopharmaceuticals in the prevention of sepsis and septic sequelae. J Endotoxin Res 2:203-208
16. Williams DL, Ha T, Li C, Kalbfleish JH, Schweitzer J, Vogt W, Browder IW (2003) Modulation of tissue Toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality. Crit Care Med 31:1808-1818
17. Babineau TJ, Hackford A, Kenler A, Bistrian B, Forse RA, Fairchild PG, Heard S, Keroack M, Caushaj P, Benotti P (1994) A phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (PGG-glucan) in high surgical patients. Arch Surg 129:1204-1210
18. Dellinger EP, Babineau TJ, Bleicher P, Kaiser AB, Seibert GB, Postier RG, Vogel SB, Norman J, Kaufman D, Galandiuk S, Condon RE (1999) Effect of PGG-glucan on the rate of serious postoperative infection or death observed after high-risk gastrointestinal operations. Arch Surg 134:977-983
19. Williams DL, Li C, Ha T, Ozment-Skelton T, Kalbfleisch JH, Preiszner J, Brooks L, Breuel K, Schweitzer JB (2004) Modulation of the phosphoinositide 3-kinase pathway alters innate resistance to polymicrobial sepsis. J Immunol 172:449-456
20. Schmekel B, Karlsson SE, Linden M, Sundstrom C, Tegner H, Venge P (1990) Myeloperoxidase in human lung lavage. A marker of local neutrophil activity. Inflammation 14:445-447
21. Griswold J, Maier RV (1988) Neutrophil phagocytosis, during endotoxin-induced lung injury. J Surg Res 44:417-424
22. Lazaron V, Barke A (1999) Gram-negative bacterial sepsis and the sepsis syndrome. Urol Clin North Am 26:687-699
23. Modig J, Samuelsson T, Hallgren R (1986) The predictive and discriminative value of biologically active products of eosinophils, neutrophils and complement in bronchoalveolar lavage and blood in patients with adult respiratory distress syndrome. Resuscitation 14:121-134
24. Akira S, Kishimoto T (1996) Role of interleukin-6 in macrophage function. Curr Opin Hematol 3:87-93
25. Jones SA, Horiuchi S, Topley N, Yamamoto N, Fuller GM (2001) The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J 15:43-58
26. Blacwell TS, Christman JW (1996) Sepsis and cytokines: current status. Br J Anaesth 77:110-117
27. Masih NK, Madaj K, Hintelmann H, Gast G, Kaneko Y (1997) Down-regulation of tumor necrosis factor a moderato reduction of interleukin-1β but not interleukin-6 or interleukin-10 by glucan immunomodulators curdlan sulfate and lentinen. Int J Immunopharmacol 19:463-468
28. Rasmussen LT, Seljelid R (1991) Novel immunomodulators with pronounced in vivo effect caused by stimulation of cytokine release. J Cell Biochem 46:60-68
29. Tokunaka K, Ohno N, Adachi Y, Tanaka S, Tamura H, Yadomae T (2000) Immunopharmacological and immunotoxicological activities of a water-soluble (1>3)- β-D-glucan, CSBG from Candida spp. Int J Immunopharmacol 22:383-394
30. Yin K, Wilmenski J, Wang CQ, Thamont M (2000) Lung compartmentalization of inflammatory cell in sepsis. Inflammation 24:543-557
31. Czermak BJ, Breckwoldt M, Ravage ZB, Huber-Lang M, Schmal H, Bless NM, Friedl HP, Ward PA (1999) Mechanisms of enhanced lung injury during sepsis. Am J Pathol 154:1057-1065